MedTrace Logo

The Effect of Cranberry Extract Supplementation on Cardiovascular Risk Factors in Obese, Insulin Resistant Humans

NCT02068144 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2018-08-28

No results posted yet for this study

Summary

The purpose of this study is to determine the health benefits of cranberry extract in people who are at risk for diabetes and heart problems.

Conditions

Interventions

DIETARY_SUPPLEMENT

Cranberry Extract

Participants will drink one 15.2 oz bottle of Cranberry Extract beverage daily for 8 weeks.

OTHER

Placebo

Participants will drink one 15.2oz bottle of placebo beverage daily for 8 weeks.

Sponsors & Collaborators

  • Ocean Spray, Inc.

    collaborator INDUSTRY

  • Pennington Biomedical Research Center

    lead OTHER

Principal Investigators

  • Daniel Hsia, MD · Principal and Medical Investigator

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2016-06-02
Completion
2018-07-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02068144 on ClinicalTrials.gov